Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:578527.
doi: 10.1155/2015/578527. Epub 2015 May 24.

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD

Stephan Buderus  1 , James H Boone  2 , Michael J Lentze  3
Affiliations

Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD

Stephan Buderus et al. Gastroenterol Res Pract. 2015.

Abstract

Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in stool specimens collected prior to endoscopy for IBD (IBD-SCAN; TechLab, Blacksburg; normal < 7.3 µg/g feces). CRP was detected in serum (normal < 5 mg/L). Three patient groups were determined: n = 21 (mean age 13.2) with Crohn's disease (CD), n = 15 (mean age 10.9) with ulcerative colitis (UC), and n = 20 (mean age 11.9) in whom IBD was ruled out. In CD patients the endoscopic severity score SES-CD was correlated with the FL levels. Results. (Mean ± SEM). CRP levels were 27.18 ± 4.2 for CD-cases, 20.8 ± 9.5 for UC, and 0.24 ± 0.06 for non-IBD patients. FL levels were 313.6 ± 46.4 in CD, 370.7 ± 46.9 in UC, and 1.3 ± 0.5 in non-IBD patients. Sensitivity of CRP to detect IBD was 75% with specificity of 100%, positive predictive value of 100%, and negative predictive value of 69%. Sensitivity of FL was 100% with specificity of 95%, positive predictive value of 97.3%, and negative predictive value of 100%. In CD, FL levels correlated positively (R (2) = 0.42) with disease severity as judged by the SES-CD. Conclusions. Elevated FL corresponds to intestinal inflammation, even in patients with normal CRP. With high probability, normal FL excludes intestinal inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Patient and endoscopy flowchart.
Figure 2
Figure 2
Serum-CRP levels stratified for groups of patients. P < 0.0001 IBD versus control and CD versus control. P = 0.017 UC versus control. P = 0.50 for CD versus UC.
Figure 3
Figure 3
Fecal lactoferrin levels stratified for groups of patients. P < 0.0001 for each IBD, CD, and UC versus control. P = 0.41 for CD versus UC.
Figure 4
Figure 4
CD patients: fecal lactoferrin and the endoscopic score SES-CD, linear regression line depicted in the graph.
See this image and copyright information in PMC

References

    1. Auvin S., Molinié F., Gower-Rousseau C., et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988–1999) Journal of Pediatric Gastroenterology & Nutrition. 2005;41(1):49–55. doi: 10.1097/01.mpg.0000162479.74277.86. - DOI - PubMed
    1. Benchimol E. I., Guttmann A., Griffiths A. M., et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: Evidence from health administrative data. Gut. 2009;58(11):1490–1497. doi: 10.1136/gut.2009.188383. - DOI - PubMed
    1. Hildebrand H., Finkel Y., Grahnquist L., Lindholm J., Ekbom A., Askling J. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001. Gut. 2003;52(10):1432–1434. doi: 10.1136/gut.52.10.1432. - DOI - PMC - PubMed
    1. Kugathasan S., Judd R. H., Hoffmann R. G., et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. Journal of Pediatrics. 2003;143(4):525–531. doi: 10.1067/s0022-3476(03)00444-x. - DOI - PubMed
    1. Eszter Müller K., Laszlo Lakatos P., Papp M., Veres G. Incidence and paris classification of pediatric inflammatory bowel disease. Gastroenterology Research and Practice. 2014;2014:10. doi: 10.1155/2014/904307.904307 - DOI - PMC - PubMed

LinkOut - more resources